TSS
HRTX icon

Two Sigma Securities’s Heron Therapeutics HRTX Stock Holding History

Two Sigma Securities’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.86K Buy
+20,754
New +$16.6K ﹤0.01% 1565
2026
Q1 		– Sell
-12,136
Closed -$15.8K – 1869
2025
Q4 		$15.8K Buy
+12,136
New +$15K ﹤0.01% 1218
2025
Q3 		– Sell
-14,376
Closed -$29.8K – 1665
2025
Q2 		$29.8K Buy
+14,376
New +$29.4K ﹤0.01% 1155
2022
Q3 		– Sell
-10,685
Closed -$30K – 2813
2022
Q2 		$30K Buy
+10,685
New +$42.9K ﹤0.01% 1904

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Two Sigma Securities's HRTX Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Heron Therapeutics (HRTX) in Q2 2026: 20,754 shares worth $8.86K. The stake represents ﹤0.01% of the portfolio and ranks #1565 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in HRTX as recently as Q4 2025.

Two Sigma Securities first reported a position in HRTX in Q2 2022 and has held it in 4 quarters since. The position peaked at $30K in Q2 2022. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Two Sigma Securities held 20,754 shares of Heron Therapeutics worth $8.86K as of Q2 2026.
  • Heron Therapeutics was a new Two Sigma Securities position in Q2 2026.
  • Heron Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1565 holding.
  • Two Sigma Securities first reported a position in Heron Therapeutics in Q2 2022 and has held it in 4 quarters since.
  • Two Sigma Securities's Heron Therapeutics position peaked at $30K in Q2 2022.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.